Supplementary protection
LT - 3-[5-(2-fluorfenil)-[1,2,4]oksadiazol-3-il]benzenkarboksirūgšties kristalinės formos
EN - CRYSTALLINE FORMS OF 3-[5-(2-FHJOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID
SPC
| (11) |
Number of the document |
C 2076501 |
| (68) |
Number of the document |
2076501
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2016 012 |
| (22) |
Date of filing the application |
2016-04-22 |
| (41) |
Date of publication of the application |
2016-05-25 |
|
Date of publication of SPC |
2017-10-10 |
| (24) |
Date of coming into effect of SPC |
2027-09-25 |
Applicant
| (71) |
PTC Therapeutics, Inc.,
100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080,
US
|
Grantee
| (73) |
PTC Therapeutics, Inc.,
100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/13/902, 2014-07-31
|
Calculated date of expiry of the SPC
| (94) |
2029-08-05 |
Name of the product protected by the basic patent
| (95) |
Atalurenas |
